The therapeutic promise of PHGDH inhibition is tempered by neurotoxicity risks stemming from central serine depletion [16, 101], recapitulating neurological deficits observed in Neu-Laxova syndrome [93]. Here, PHGDH is linked to Neu-Laxova syndrome.